Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Cathy, Viglianti"'
Publikováno v:
Annales de biologie clinique. 68:325-329
Human epididymis protein 4 (HE4) is a novel marker for ovarian cancer. HE4 exhibits a high sensitivity to detect ovarian cancer and can be used with CA125 as a predictor of malignancy. Additional uses of HE4 are as an aid of monitoring response to th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0fbb5096ba5f0dcd69580dbe86e00829
https://doi.org/10.1684/abc.2010.0435
https://doi.org/10.1684/abc.2010.0435
Autor:
Simon Thezenas, Frédéric Bibeau, Pierre-Jean Lamy, William Jacot, Anne-Claire Laberenne, Jean-Pierre Bleuse, Gilles Romieu, Evelyne Lopez-Crapez, Cathy Viglianti, Romain Senal
Publikováno v:
BMC Cancer
Background: Poly(adenosine diphosphate–ribose) polymerase 1 (PARP-1) and the balance between BRCA1 and 53BP1 play a key role in the DNA repair and cell stress response. PARP inhibitors show promising clinical activity in metastatic triple negative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1017abf9316c5f678dc988343693db27
https://pubmed.ncbi.nlm.nih.gov/24191908
https://pubmed.ncbi.nlm.nih.gov/24191908
Publikováno v:
Annales de biologie clinique. 68(3)
Human epididymis protein 4 (HE4) is a novel marker for ovarian cancer. HE4 exhibits a high sensitivity to detect ovarian cancer and can be used with CA125 as a predictor of malignancy. Additional uses of HE4 are as an aid of monitoring response to th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f0976ef8e178d2db4c72605a420460ec
https://pubmed.ncbi.nlm.nih.gov/20478777
https://pubmed.ncbi.nlm.nih.gov/20478777